Tech Company Financing Transactions
BattellePharma Funding Round
BattellePharma, operating out of Columbus, raised $22 million from TL Ventures, Battelle Ventures and Fletcher Spaght Ventures.
Transaction Overview
Company Name
Announced On
2/19/2003
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series B
Investors
TL Ventures (Lead Investor) (Marc Ostro)
Proceeds Purpose
The capital will be used to fund BattellePharma?s operations through mid-2005.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1801 Watermark Dr. 100
Columbus, OH 43215
USA
Columbus, OH 43215
USA
Phone
Email Address
Not Recorded
Overview
BattellePharma is a privately-held specialty pharmaceutical company leveraging science and technology to design more effective medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Cearlock
Browse more venture capital transactions:
Prev: 2/19/2003: Widevine Technologies venture capital transaction
Next: 2/19/2003: NuCORE Technology venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs